Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG in Aplastic Anemia and Hematologic Disorders
NCT00000597Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Mar 1982
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
01
Overview
Phase 3, randomised, open-label trial of antithymocyte globulin rabbit in aplastic anemia and bone marrow failure (5 arms), sponsored by National Heart, Lung, and Blood Institute. Primary endpoint: Therapeutic effects of anti-thymocyte globulin. Started Mar 1982; status: completed.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
aplastic anemiabone marrow failure
Beyond the preview
Go deeper on NCT00000597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000597.